Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations

Journal of the American College of Cardiology

Volumn 64, Issue 24, 2014, Pages 2589-2600

  Coppini, Raffaele ^a   Ho, Carolyn Y ^b   Ashley, Euan ^c   Day, Sharlene ^d   Ferrantini, Cecilia ^a   Girolami, Francesca ^e   Tomberli, Benedetta ^e   Bardi, Sara ^e   Torricelli, Francesca ^e   Cecchi, Franco ^e   Mugelli, Alessandro ^a   Poggesi, Corrado ^a   Tardiff, Jil ^f   Olivotto, Iacopo ^e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

correlation triphasic filling troponin; diastolic function end stage; genotype to phenotype

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; VERAPAMIL; ACTC1 PROTEIN, HUMAN; ACTIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TNNI3K PROTEIN, HUMAN; TNNT2 PROTEIN, HUMAN; TROPONIN T;

ADULT; ARTICLE; CATHETER ABLATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HEART DEATH; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MYBPC3 GENE; MYH7 GENE; MYL2 GENE; MYOFILAMENT; NEW YORK HEART ASSOCIATION CLASS; PHENOTYPE; PREVALENCE; THIN FILAMENT; ACTIN FILAMENT; CARDIOMYOPATHY, HYPERTROPHIC; COMPARATIVE STUDY; COMPLICATION; DEATH, SUDDEN, CARDIAC; DISEASE COURSE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; ITALY; MIDDLE AGED; MUTATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VENTRICULAR FIBRILLATION; VENTRICULAR OUTFLOW OBSTRUCTION;

ACTIN CYTOSKELETON; ACTINS; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEART FUNCTION TESTS; HUMANS; ITALY; MALE; MAP KINASE KINASE KINASES; MIDDLE AGED; MUTATION; PATIENT OUTCOME ASSESSMENT; SEVERITY OF ILLNESS INDEX; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84917690934     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.09.059     Document Type: Article

References (38)

1. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715
2. I. Olivotto, F. Girolami, and M.J. Ackerman Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy Mayo Clin Proc 83 2008 630 638
3. L. Thierfelder, H. Watkins, and C. MacRae Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere Cell 77 1994 701 712
4. J.C. Tardiff Thin filament mutations: developing an integrative approach to a complex disorder Circ Res 108 2011 765 782
5. S.L. Van Driest, E.G. Ellsworth, S.R. Ommen, A.J. Tajik, B.J. Gersh, and M.J. Ackerman Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy Circulation 108 2003 445 451
6. J.C. Tardiff Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes Heart Fail Rev 10 2005 237 248
7. H. Watkins, W.J. McKenna, and L. Thierfelder Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1995 1058 1064
8. J.C. Moolman, V.A. Corfield, and B. Posen Sudden death due to troponin T mutations J Am Coll Cardiol 29 1997 549 555
9. A. Doolan, M. Tebo, and J. Ingles Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences J Mol Cell Cardiol 38 2005 387 393
10. A. Karibe, L.S. Tobacman, and J. Strand Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis Circulation 103 2001 65 71
11. M.J. Ackerman, S.L. VanDriest, and S.R. Ommen Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective J Am Coll Cardiol 39 2002 2042 2048
12. F. Pasquale, P. Syrris, J.P. Kaski, J. Mogensen, W.J. McKenna, and P. Elliott Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene Circ Cardiovasc Genet 5 2012 10 17
13. B.J. Gersh, B.J. Maron, R.O. Bonow American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 58 2011 e212 e260
14. M.S. Maron, I. Olivotto, and S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
15. P.M. Elliott, J.R. Gimeno Blanes, N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
16. N.K. Lakdawala, J.J. Thune, and B.J. Maron Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy Am J Cardiol 108 2011 1606 1613
17. J.N. Johnson, C. Grifoni, and J.M. Bos Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy Eur Heart J 32 2011 1114 1120
18. Wallis Y, Payne S, McAnulty C, et al. Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Available at: http://www.acgs.uk.com/media/774853/evaluation-and-reporting-of-sequence-variants-bpgs-june-2013-finalpdf.pdf. Accessed October 7, 2014.
19. R.A. Nishimura, and A.J. Tajik Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone J Am Coll Cardiol 30 1997 8 18
20. B. Pinamonti, A. Di Lenarda, G. Sinagra, F. Camerini Heart Muscle Disease Study Group Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications J Am Coll Cardiol 22 1993 808 815
21. J.W. Ha, J.K. Oh, M.M. Redfield, K. Ujino, J.B. Seward, and A.J. Tajik Triphasic mitral inflow velocity with middiastolic filling: clinical implications and associated echocardiographic findings J Am Soc Echocardiogr 17 2004 428 431
22. E. Biagini, M. Lorenzini, and I. Olivotto Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis BMJ Open 2 2012 e001267
23. Authors/Task Force members P.M. Elliott, A. Anastasakis Authors/Task Force Members 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2014 2733 2779
24. I. Olivotto, F. Cecchi, C. Poggesi, and M.H. Yacoub Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging Circ Heart Fail 5 2012 535 546
25. M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
26. K. Debl, B. Djavidani, and S. Buchner Triphasic mitral inflow pattern and regional triphasic mitral annulus velocity in hypertrophic cardiomyopathy J Am Soc Echocardiogr 21 2008 407.e5 407.e6
27. C.S. Lam, L. Han, J.W. Ha, J.K. Oh, and L.H. Ling The mitral L wave: a marker of pseudonormal filling and predictor of heart failure in patients with left ventricular hypertrophy J Am Soc Echocardiogr 18 2005 336 341
28. A.Q. Araujo, E. Arteaga, V.M. Salemi, and C. Mady Triphasic left ventricular filling in hypertrophic cardiomyopathy Heart 91 2005 538
29. O. Bruder, A. Wagner, and C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
30. G. Todiere, G.D. Aquaro, and P. Piaggi Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 60 2012 922 929
31. K.M. Harris, P. Spirito, and M.S. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
32. I. Olivotto, F. Cecchi, and R. Gistri Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
33. T. Kubo, J.R. Gimeno, and A. Bahl Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype J Am Coll Cardiol 49 2007 2419 2426
34. H. He, K. Hoyer, and H. Tao Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific J Physiol 590 2012 5371 5388
35. D. Lin, A. Bobkova, E. Homsher, and L.S. Tobacman Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy J Clin Invest 97 1996 2842 2848
36. T. Miller, D. Szczesna, and P.R. Housmans Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation J Biol Chem 276 2001 3743 3755
37. M.M. Javadpour, J.C. Tardiff, I. Pinz, and J.S. Ingwall Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T J Clin Invest 112 2003 768 775
38. R. Coppini, C. Ferrantini, and L. Yao Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy Circulation 127 2013 575 584